|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 403/14 | |||
| C07D 413/14 | |||
| C07D 417/14 | |||
| A61K 31/41 | |||
| A61K 31/435 | |||
| A61K 31/495 | |||
| A61P 7/00 | |||
| A61P 9/00 |
| (11) | Number of the document | 2383269 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11175197.0 |
| Date of filing the European patent application | 2007-10-12 | |
| (97) | Date of publication of the European application | 2011-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 102006050516 | 2006-10-26 | DE |
| (72) |
Thede, Kai, DE
Flamme, Ingo, DE
Oehme, Felix, DE
Ergüden, Jens-Kerim, DE
Stoll, Friederike, DE
Schuhmacher, Joachim, DE
Wild, Hanno, DE
Kolkhof, Peter, DE
Beck, Hartmut, DE
Keldenich, Jörg, DE
Akbaba, Metin, DE
Jeske, Mario, DE
|
| (73) |
Bayer Intellectual Property GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | Substituierte Dihydropyrazolone zur Behandlung von Herz-Kreislauf-Erkrankungen |
| Substituted Dihydropyrazolones for the treatment of cardiovascular diseases |